rev1 engineering and filmecc- medical device design and manufacturing logo

ASAHI INTECC AND REV.1 ENGINEERING® Support Medical Device Startups at AdvaMed and The MedTech Conference

Table of Contents
Upcoming Events

Representatives from ASAHI INTECC and REV.1 Engineering were proud participants in this year’s combined AdvaMed and The MedTech Conference in Boston. REV.1 Engineering is a wholly owned subsidiary of ASAHI INTECC, and is recognized as one of the country’s leading design, development and strategic manufacturing firms. REV.1 specializes in sophisticated, minimally invasive, often First of Kind technologies.

ASAHI INTECC, a global leading in guidewire technologies, is a generous sponsor of MedTech Innovator. MedTech Innovator is one of the nation’s foremost incubator/ accelerators for startup medical device companies, and a key organizer for The MedTech Conference. Along with ASAHI, REV.1 provides its expertise in early-stage startup strategy, engineering and manufacturing through MedTech’s ongoing mentorship program.

“Having been in the med device startup world for over twenty years, I’ve been around more than a few incubator/accelerators,” said Terry Murray, Vice President of Strategic Development for REV.1 Engineering. “They all have great intention, but only a few truly deliver on the vision of what an accelerator can be. MedTech Innovator is one of them. It’s truly an honor to work with them in support of these promising startups.”

To quote from MedTech’s website: “MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator unites leading players in the Medtech Innovation Ecosystem.”

Most importantly, MedTech connects startup founders and their teams with industry experts and investors interested in accelerating the commercialization of transformational medical technologies. It’s a formula that works! The alumni of their annual programs have gone on to raise more than $4 billion in equity financing.

Interested in learning how REV.1 Engineering can help accelerate your road to market? Please feel free to contact us here!

© 2022, REV.1 Engineering®.

From the picture above, left to right: Terry Murray, REV.1 Engineering, Dr. John Wong, Founder and CEO of Fluid Biomed (http://fluidbiomed.com), John Schindler Founder and CEO of Liquet Medical (https://www.liquetmedical.com/), Martin Grasse Founder and CEO of Gradient Denervation (https://gradientdenervation.com/), and Toufic Azar, Founder and CEO of Meacor (http://meacor.com).